Two Therapies To Treat Sickle Cell Disease Are Underutilized
A panel of experts reviewed more than 30 years of studies on sickle cell disease, to create a new guideline for managing the disease. The report highlights two therapies, the use of the drug hydroxyurea and blood transfusions, that are effective but underutilized when it comes to treatment.
PRESS RELEASE DOWNLOAD
The JAMA Network Media Relations-United Statesmediarelations@jamanetwork.org3124645262